Literature DB >> 12691260

Integrin alphavbeta3 binding to human alpha5-laminins facilitates FGF-2- and VEGF-induced proliferation of human ECV304 carcinoma cells.

Elke Genersch1, Maria Ferletta, Ismo Virtanen, Hermann Haller, Peter Ekblom.   

Abstract

Human ECV304 cells respond reproducibly by tube formation to complex basement membrane matrices. Laminins are major glycoproteins of basement membranes. We therefore studied the ability of ECV304 cells to attach to defined laminin isoforms and to fibronectin, and identified the involved laminin receptors. The cells bound poorly to fibronectin, to some extent to laminin-1, whereas laminin-2/4 and -10/11 were strong adhesive substrates. Antibody perturbation assays showed that adhesion to laminin-1 was mediated by integrin alpha6beta1, and adhesion to laminin-2/4 by cooperative activity of integrins alpha3beta1 and alpha6beta1. Adhesion of ECV 304 cells to laminin-10/11 was mainly mediated by integrins alpha3beta1, with minor involvement of alpha6beta1/4 and alphavbeta3. Solid-phase binding assays confirmed that integrin alphavbeta3 binds human laminin-10/11 and -10, in an RGD-dependent fashion. Although integrin alphavbeta3 played a very minor role in cell adhesion to laminin-10/11, this interaction facilitated growth factor-induced proliferation of ECV304 cells. In response to FGF-2 or VEGF, the cells proliferated better when attached on laminin-10/11 than on laminin-1, -2/4, or gelatin. The proliferation induced by the joint application of laminin-10/11 and either one of the growth factors could be blocked by antibodies against integrin alphavbeta3. Fragments of several other basement membrane components are known to interact with alphavbeta3. The current data show that that integrin alphavbeta3 can bind intact alpha5-containing laminin trimers. Since the laminin alpha5 chain is broadly expressed in adult basement membranes, this interaction could be physiologically important. Our data suggest that this interaction is involved in the regulation of cellular responses to growth factors known to be involved in epithelial and endothelial development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691260     DOI: 10.1078/0171-9335-00297

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  9 in total

1.  Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation.

Authors:  Maria Ferletta; Yamato Kikkawa; Hao Yu; Jan F Talts; Madeleine Durbeej; Arnoud Sonnenberg; Rupert Timpl; Kevin P Campbell; Peter Ekblom; Elke Genersch
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

2.  c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5.

Authors:  Xiuhai Ren; Jingying Xu; Jason P Cooper; Min H Kang; Anat Erdreich-Epstein
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

3.  Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture.

Authors:  Victoria J Burton; Lynn M Butler; Helen M McGettrick; Phil C Stone; Hannah C Jeffery; Caroline O Savage; G Ed Rainger; Gerard B Nash
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

4.  Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis.

Authors:  Shashi K Gopal; David W Greening; Hong-Jian Zhu; Richard J Simpson; Rommel A Mathias
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

5.  Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice.

Authors:  Delma Veron; Pardeep K Aggarwal; Qi Li; Gilbert Moeckel; Michael Kashgarian; Alda Tufro
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

Review 6.  Integrins.

Authors:  Malgorzata Barczyk; Sergio Carracedo; Donald Gullberg
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

7.  Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy.

Authors:  W Nathaniel Brennen; Daniel L J Thorek; Wen Jiang; Timothy E Krueger; Lizamma Antony; Samuel R Denmeade; John T Isaacs
Journal:  Immunotherapy       Date:  2020-11-05       Impact factor: 4.196

8.  A novel monoclonal antibody to human laminin α5 chain strongly inhibits integrin-mediated cell adhesion and migration on laminins 511 and 521.

Authors:  Zenebech Wondimu; Shahin Omrani; Taichi Ishikawa; Fawad Javed; Yuko Oikawa; Ismo Virtanen; Erkki Juronen; Sulev Ingerpuu; Manuel Patarroyo
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

9.  Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.

Authors:  Liming Shang; Xinping Ye; Guangzhi Zhu; Hao Su; Zhixiong Su; Bin Chen; Kaiyin Xiao; Lequn Li; Minhao Peng; Tao Peng
Journal:  Oncotarget       Date:  2017-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.